Reneo Pharmaceuticals, Inc.'s latest layoff filing, on February 23, 2024, states charges of approximately $1.7 million. As of November 14, 2026, it has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, February 23, 2024).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Reneo Pharmaceuticals, Inc.
Free to see. No signup.
People from Reneo Pharmaceuticals, Inc. who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the Reneo Pharmaceuticals, Inc. layoff? Add yourself to the open-to-work list, free
Your entry
Reneo Pharmaceuticals, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Reneo Pharmaceuticals have layoffs in 2024? What its filings say
Reneo Pharmaceuticals, Inc. (CIK 1637715) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2024-02-23
Expected charges
In connection with the Second Reduction, the Company estimates that it will incur charges of approximately $1.7 million associated with cash severance payments and other employee termination-related costs in the first quarter of 2024.
Timing
As part of the plan of implementing cost saving initiatives announced by Reneo Pharmaceuticals, Inc. (the "Company") on December 14, 2023, the Company expects to complete a second workforce reduction of approximately 20% on February 29, 2024 (the "Second Reduction").
Also on the record for Reneo Pharmaceuticals, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 7, 2026 | Stake report, Schedule 13G, by Coastlands Capital LP | 6.67% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by ADAR1 Capital Management, LLC | 5.5% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by BVF PARTNERS L P/IL | 8% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Trails Edge Capital Partners, LP | 3.6% of the class | 5%+ stakes | Source |
| August 13, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| August 10, 2026 | Stake report, Schedule 13G/A, by Prosight Management, LP | 2.4% of the class | 5%+ stakes | Source |
| May 27, 2026 | Stake report, Schedule 13G, by BVF PARTNERS L P/IL | 5.3% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by ADAR1 Capital Management, LLC | 6% of the class | 5%+ stakes | Source |
| April 7, 2026 | Stake report, Schedule 13D, by AI Biotechnology LLC | 19.99% of the class | 5%+ stakes | Source |
| April 7, 2026 | Stake report, Schedule 13G, by RA Capital Management, L.P. | 9.9% of the class | 5%+ stakes | Source |
| April 7, 2026 | Stake report, Schedule 13G, by StepStone Group LP | 6.6% of the class | 5%+ stakes | Source |
| April 7, 2026 | Stake report, Schedule 13G, by Trails Edge Capital Partners, LP | 6% of the class | 5%+ stakes | Source |
Keep reading
More on Reneo Pharmaceuticals, Inc. and the records around it.
Reneo Pharmaceuticals, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Leadership changes Aug 2026
- Who owns it
Companies that share a holder
- StepStone Group LP also filed stake reports on 2 other companies: StepStone Private Equity Strategies Fund (May 2026)
- AI Biotechnology LLC also filed stake reports on 3 other companies: Latigo Biotherapeutics, Inc. (Nov 2026), Yarrow Bioscience, Inc. (Jul 2026), Zura Bio Limited (Mar 2026)
- Cantor Fitzgerald Securities also filed stake reports on 3 other companies: Satellogic Inc. (Mar 2026), M3-Brigade Acquisition V Corp. (Mar 2026), Sono Group N.V. (Feb 2026)
Watch Reneo Pharmaceuticals, Inc.
Get an email when Reneo Pharmaceuticals, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Reneo Pharmaceuticals, Inc.?
Want the whole picture on Reneo Pharmaceuticals, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Reneo Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Reneo Pharmaceuticals, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 23 records.
Tools for this story
Each opens in a new tab, filled in for Reneo Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Who owns OnKure Therapeutics, Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/reneo-pharmaceuticals